IP Verse

Boehringer Ingelheim Pharma Gmbh & Co. Kg opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg

Patent Number:
EP3219328
Title:
Human Anti-Il-23 Antibodies, Compositions, Method And Uses
Applicant:
JANSSEN BIOTECH, INC.
Opposition Date:
Mar 17, 2021
Patent Number:
EP2634243
Title:
Improved Process For The Culturing Of Cells
Applicant:
DPX HOLDINGS B.V.
Opposition Date:
Jun 5, 2018
Patent Number:
EP2634242
Title:
Improved Process For The Culturing Of Cells
Applicant:
DPX HOLDINGS B.V.
Opposition Date:
Jan 4, 2018
Patent Number:
EP2634250
Title:
Improved Process For The Culturing Of Cells
Applicant:
DPX HOLDINGS B.V.
Opposition Date:
Jan 4, 2018

Latest patents of Boehringer Ingelheim Pharma Gmbh & Co. Kg opposed by its competitors

Patent:
EP2397142
Grant Date:
Jul 27, 2022
Title:
Use Of Dpp Iv Inhibitors
Oppositions:
5
Patent:
EP2152341
Grant Date:
Dec 11, 2019
Title:
Atomizer, And Filter
Oppositions:
2
Patent:
EP2433665
Grant Date:
Aug 7, 2019
Title:
Inhaler And Sieve For An Inhaler
Oppositions:
1
Patent:
EP1940349
Grant Date:
Feb 14, 2018
Title:
Aerosol Formulation For The Inhalation Of Beta Agonists
Oppositions:
1

Competitors of Boehringer Ingelheim Pharma Gmbh & Co. Kg

DPX HOLDINGS B.V.

DSM IP ASSETS B.V.

PATHEON HOLDINGS I B.V.

Want to track Boehringer Ingelheim Pharma Gmbh & Co. Kg?

Feel free to send us a message here and we will get back to you